Caplin Point Laboratories LimitedNSE: CAPLIPOINT

Press Release Dec 24 2020

· Issued by Caplin Point Laboratories Limited

Filed with NSE ·

Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated December 24, 2020, titled "CAPLIN STERILES GETS USFDA APPROVAL FOR ETOMIDATE INJECTION USP".

View Attachment

6ix hasn’t read this filing yet.

Caplin Point Laboratories Limited on 6ix

Later from Caplin Point Laboratories

All Caplin Point Laboratories news releases